Comparing Topical Treatments for Basal Cell Carcinoma
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (3) , 484-486
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012JAMA Dermatology, 2015
- It's time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer”Journal of the American Academy of Dermatology, 2015
- Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinomaBritish Journal of Dermatology, 2014
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trialThe Lancet Oncology, 2013
- What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trialBMC Dermatology, 2012
- Trends in the incidence of basal cell carcinoma by histopathological subtypeJournal of the European Academy of Dermatology and Venereology, 2010
- Actinic keratosesCancer, 2009
- Survey among patients with basal cell carcinoma in The NetherlandsJournal of Dermatological Treatment, 2009
- A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-upBritish Journal of Dermatology, 2007
- Differences in Age, Site Distribution, and Sex Between Nodular and Superficial Basal Cell Carcinomas Indicate Different Types of TumorsJournal of Investigative Dermatology, 1998